Shares of Sotera Health (NYSE:SHC) have earned an average rating of “Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $32.45.
Several research analysts have weighed in on the company. Barclays upped their target price on Sotera Health from $30.00 to $32.00 and gave the stock an “overweight” rating in a research report on Friday, August 13th. Zacks Investment Research lowered Sotera Health from a “buy” rating to a “hold” rating in a research report on Wednesday.
In other news, insider Michael P. Rutz sold 67,000 shares of the company’s stock in a transaction dated Wednesday, August 25th. The stock was sold at an average price of $25.03, for a total transaction of $1,677,010.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 64.95% of the company’s stock.
NYSE:SHC traded down $0.01 during trading hours on Thursday, hitting $25.80. 465,345 shares of the company’s stock traded hands, compared to its average volume of 1,041,395. The firm has a market cap of $7.30 billion and a P/E ratio of 67.89. Sotera Health has a twelve month low of $21.21 and a twelve month high of $30.38. The company has a debt-to-equity ratio of 3.58, a quick ratio of 2.46 and a current ratio of 2.70. The stock’s fifty day moving average price is $24.04 and its two-hundred day moving average price is $24.56.
Sotera Health (NYSE:SHC) last posted its quarterly earnings results on Thursday, August 12th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. The business had revenue of $251.92 million for the quarter, compared to analyst estimates of $226.27 million. On average, equities research analysts predict that Sotera Health will post 0.85 earnings per share for the current year.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
Recommended Story: How To Calculate Debt-to-Equity Ratio
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.